269 related articles for article (PubMed ID: 15362257)
1. Venlafaxine-associated hypomania in unipolar depression.
Chand PK; Kalyani GS; Murthy P
Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
[No Abstract] [Full Text] [Related]
2. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.
Liberek C; Aubry JM; Baud P
Therapie; 2006; 61(6):531-3. PubMed ID: 17348610
[No Abstract] [Full Text] [Related]
3. Withdrawal syndrome after discontinuation of venlafaxine.
Agelink MW; Zitzelsberger A; Klieser E
Am J Psychiatry; 1997 Oct; 154(10):1473-4. PubMed ID: 9326838
[No Abstract] [Full Text] [Related]
4. Venlafaxine-induced hair loss.
Pitchot W; Ansseau M
Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
[No Abstract] [Full Text] [Related]
5. Venlafaxine withdrawal reactions.
Louie AK; Lannon RA; Kirsch MA; Lewis TB
Am J Psychiatry; 1996 Dec; 153(12):1652. PubMed ID: 8942467
[No Abstract] [Full Text] [Related]
6. Treatment of venlafaxine discontinuation symptoms with ondansetron.
Raby WN
J Clin Psychiatry; 1998 Nov; 59(11):621-2. PubMed ID: 9862610
[No Abstract] [Full Text] [Related]
7. Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
Bertolín-Guillén JM; Climent-Díaz B; Navarré-Gimeno A
Eur Psychiatry; 2004 Nov; 19(7):456-7. PubMed ID: 15504661
[No Abstract] [Full Text] [Related]
8. Benztropine in the treatment of venlafaxine-induced sweating.
Garber A; Gregory RJ
J Clin Psychiatry; 1997 Apr; 58(4):176-7. PubMed ID: 9164433
[No Abstract] [Full Text] [Related]
9. Suspected complication of treatment with venlafaxine.
Wilson R; Jenkins P
J Clin Psychopharmacol; 1997 Aug; 17(4):323. PubMed ID: 9241015
[No Abstract] [Full Text] [Related]
10. Serotonin syndrome induced by administration of venlafaxine and phenelzine.
Heisler MA; Guidry JR; Arnecke B
Ann Pharmacother; 1996 Jan; 30(1):84. PubMed ID: 8773172
[No Abstract] [Full Text] [Related]
11. Possible venlafaxine-induced mania.
Stoner SC; Williams RJ; Worrel J; Ramlatchman L
J Clin Psychopharmacol; 1999 Apr; 19(2):184-5. PubMed ID: 10211922
[No Abstract] [Full Text] [Related]
12. Venlafaxine-associated mania.
Shulman RB; Scheftner WA; Nayudu S
J Clin Psychopharmacol; 2001 Apr; 21(2):239-41. PubMed ID: 11270924
[No Abstract] [Full Text] [Related]
13. Onset of confusion in the context of late-life depression.
Mulsant BH
J Psychiatry Neurosci; 2007 Mar; 32(2):152. PubMed ID: 17353943
[No Abstract] [Full Text] [Related]
14. [Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
Tak LM; Stevens AW
Tijdschr Psychiatr; 2013; 55(10):795-800. PubMed ID: 24166339
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant options: venlafaxine in perspective.
Thase ME
J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
[TBL] [Abstract][Full Text] [Related]
16. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.
Teitelbaum M
Psychosomatics; 2001; 42(5):440-1. PubMed ID: 11739916
[No Abstract] [Full Text] [Related]
17. Venlafaxine versus fluoxetine.
Paton C
J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
[No Abstract] [Full Text] [Related]
18. [Trazodone and venlafaxine in treatment of depressive disorders].
Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine-induced urinary incontinence resolved after switching to sertraline.
Polimeni G; Salvo F; Cutroneo P; Nati G; Russo A; Giustini ES; Spina E
Clin Neuropharmacol; 2005; 28(5):247-8. PubMed ID: 16239768
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
